Waters Wins FDA Clearance for Leukemia Flow Cytometry Tests
Milford, Massachusetts, United States, November 10, 2026 Waters Corporation has announced that two ready-to-use flow cytometry clinical tests from...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine solid tumors targeted therapy
Milford, Massachusetts, United States, November 10, 2026 Waters Corporation has announced that two ready-to-use flow cytometry clinical tests from...
Maple Grove, Minnesota, United States, November 10, 2026 Francis Medical, Inc., a medical technology company specializing in minimally invasive...
Parsippany, New Jersey, USA, November 6, 2026 Onkos Surgical, Inc., a medical technology company specializing in advanced solutions for...
Belfast, Northern Ireland, United Kingdom, November 5, 2026 PulseAI, a medical technology company specializing in artificial intelligence-powered cardiac diagnostics,...
San Jose, California, United States, November 4, 2026 Evident Vascular, Inc. has announced that the U.S. Food and Drug...
Chicago, Illinois, United States, November 3, 2026 GE HealthCare has announced two new artificial intelligence (AI)-assisted capabilities for its...
Alachua, Florida, USA, November 3, 2026 Neurotronics, LLC, a Nihon Kohden company, has received U.S. Food and Drug Administration...
Indianapolis, Indiana, USA, November 2, 2026 Roche Diagnostics has announced that it has received U.S. Food and Drug Administration...
Houston, Texas, USA, November 2, 2026 Contrario Medical, Inc. has announced that it has received U.S. Food and Drug...
San Diego, California, USA, October 22, 2026 SEKISUI Diagnostics has announced the launch of its OSOM® COVID-19/Flu A&B Combo...
